MEDPACE HOLDINGS ($MEDP) posted quarterly earnings results for Q2 2026 on Wednesday, July 22nd. The company reported earnings of $4.25 per share, beating estimates of $4.05 by $0.20. The company also reported revenue of $707,330,000, beating estimates of $701,400,123 by $5,929,877.
Stock price change since market close: +17.0%
You can see Quiver Quantitative's $MEDP stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
MEDPACE HOLDINGS Insider Trading Activity
MEDPACE HOLDINGS insiders have traded $MEDP stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $MEDP stock by insiders over the last 6 months:
- JESSE J GEIGER (President) sold 31,707 shares for an estimated $14,436,197
- STEPHEN P EWALD (General Counsel & Corp. Secy.) sold 16,349 shares for an estimated $7,357,050
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
MEDPACE HOLDINGS Hedge Fund Activity
We have seen 285 institutional investors add shares of MEDPACE HOLDINGS stock to their portfolio, and 378 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GOLDMAN SACHS GROUP INC removed 178,562 shares (-51.5%) from their portfolio in Q1 2026, for an estimated $85,743,686
- FINDLAY PARK PARTNERS LLP removed 174,400 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $83,745,136
- PRICE T ROWE ASSOCIATES INC /MD/ added 172,926 shares (+148.3%) to their portfolio in Q1 2026, for an estimated $83,037,335
- JONES FINANCIAL COMPANIES LLLP added 167,185 shares (+16553.0%) to their portfolio in Q1 2026, for an estimated $80,280,565
- VULCAN VALUE PARTNERS, LLC added 155,762 shares (+329.3%) to their portfolio in Q1 2026, for an estimated $74,795,354
- QUBE RESEARCH & TECHNOLOGIES LTD removed 146,673 shares (-95.4%) from their portfolio in Q1 2026, for an estimated $70,430,907
- WASATCH ADVISORS LP removed 137,336 shares (-17.7%) from their portfolio in Q2 2026, for an estimated $72,731,772
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
MEDPACE HOLDINGS Congressional Stock Trading
Members of Congress have traded $MEDP stock 4 times in the past 6 months. Of those trades, 4 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $MEDP stock by members of Congress over the last 6 months:
- REPRESENTATIVE DAVID TAYLOR has traded it 4 times. They made 4 purchases worth up to $60,000 on 05/15, 02/26, 01/29 and 0 sales.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
MEDPACE HOLDINGS Analyst Ratings
Wall Street analysts have issued reports on $MEDP in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Jefferies issued a "Buy" rating on 02/13/2026
To track analyst ratings and price targets for MEDPACE HOLDINGS, check out Quiver Quantitative's $MEDP forecast page.
MEDPACE HOLDINGS Price Targets
Multiple analysts have issued price targets for $MEDP recently. We have seen 8 analysts offer price targets for $MEDP in the last 6 months, with a median target of $484.5.
Here are some recent targets:
- Eric Coldwell from Baird set a target price of $547.0 on 07/08/2026
- David Windley from Jefferies set a target price of $515.0 on 07/07/2026
- Ryan Halsted from RBC Capital set a target price of $484.0 on 04/24/2026
- Sean Dodge from BMO Capital set a target price of $400.0 on 04/24/2026
- Luke Sergott from Barclays set a target price of $450.0 on 04/24/2026
- Charles Rhyee from TD Cowen set a target price of $419.0 on 02/18/2026
- Michael Cherny from Leerink Partners set a target price of $485.0 on 02/11/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
